Batch-fed fermentation production method of 3-fucosyllactose
Through the batch feed fermentation production method of Escherichia coli HCYJ-08, the dynamic feeding strategy of glycerol and lactose is used to optimize the fermentation conditions, and the low yield and yield of 3-fucosyl lactose in the existing technology are solved. The problem of achieving more efficient production efficiency.
Patent Information
- Application Number
- CN202310580005.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-23
- Publication Date
- 2024-11-26
AI Technical Summary
The current 3-fucosyl lactose fermentation production process has low yield and yield, which is difficult to meet market demand.
Escherichia coli HCYJ-08 is used for batch feeding and fermentation production, using glycerol as a carbon source, by monitoring glycerol and lactose concentrations, feeding is added to improve cell density and yield, and optimized fermentation through pH regulation and stirring control condition.
The production and production efficiency of 3-fucosyl lactose per unit time is improved, and the market demand is met.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention belongs to the field of microbial fermentation engineering, and specifically relates to a fed-batch fermentation production method for 3-fucosyllactose. Background Art
[0002] 3-fucosyllactose (3-FL), CAS registration number 41312-47-4, is a white to ivory powder. As one of the main components of human milk oligosaccharides, 3-FL has the function of regulating intestinal flora and has broad application prospects in the infant food industry. Compared with the extensive research on 2'-fucosyllactose, there are currently few reports on 3-FL in the industry. However, according to safety assessments, 3-FL has no acute oral toxicity, genotoxicity, and subacute toxicity, and has been recognized as a safe substance ("Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015 / 2283", see EFSA J. Journal, Vol. 19, No. 6, 2021, e06662). The U.S. Food and Drug Administration has accepted and approved the registration application for 3-FL related infant products, such as GRN000925. 3-FL has become one of the seven human milk oligosaccharides that have been commercialized so far among more than 200 human milk oligosaccharides. 3-FL in this product is produced by genetically engineered Escherichia coli ( Escherichia coli ) BL21 (DE3) strain DSM 33491, in which one gene fragment was deleted and five genes encoding sugar metabolism functions were inserted.
[0003] In addition to the above-mentioned strains, there are also reports on the use of other strains for the production of 3-FL. For example, Sun Junsong et al. constructed a recombinant Bacillus subtilis for the fermentation production of 3-FL (CN114438001A); Hao Zhanxi et al. constructed an Escherichia coli with a knockout β-galactosidase gene for the fermentation production of 3-FL (CN112662604A); Mu Wanmeng et al. constructed an Escherichia coli expressing α1,3 fucosyltransferase for the fermentation production of 3-FL (CN114107152A); Zong Jianfei et al. constructed a genetically engineered Escherichia coli for the fermentation production of 3-FL (CN2022116286408, PCT / CN2023 / 087185).
[0004] Different Escherichia coli genetically engineered strains have undergone different genetic modifications due to metabolic pathways, etc., and their biological characteristics have changed, so there are differences in their fermentation production methods. For example, the strain published in CN114107152A uses a glycerol fermentation system and adds isopropyl β-D-thiogalactopyranoside (Isopropyl β-D-Thiogalactoside, IPTG) and lactose; the cell density index OD600nm in its fermentation process can reach 60, and the 3-FL yield can reach up to 20.3g / L. The strain published in CN114438001A can use glycerol, glucose and other fermentation systems, and the 3-FL yield can reach up to 6.2g / L. The strain of CN2022116286408 uses a glycerol fermentation system. The unoptimized fermentation process test shows that its 3-FL yield is about twice that of the control strain, but the yield is still low and the fermentation rate is slow. Currently, there are still few research reports on the fermentation production process of 3-FL, and the output and yield of its industrial production still need to be improved to meet the growing market demand. Summary of the invention
[0005] In order to solve the above technical problems, the purpose of the present invention is to improve the fermentation production process of 3-fucosyllactose to increase the yield of 3-fucosyllactose per unit time.
[0006] To achieve the above purpose, the technical solution adopted by the present invention is as follows: A method for producing 3-fucosyllactose by batch feeding fermentation, wherein the method uses Escherichia coli HCYJ-08 to ferment and produce 3-fucosyllactose, the Escherichia coli strain has a preservation number of CGMCC NO. 27189, a preservation date of April 23, 2023, a preservation unit of China National Committee for the Preservation of Microbiological Cultures, and a preservation address of No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing. It is identified and classified as Escherichia coli Escherichia coli .
[0007] The production method uses glycerol as a carbon source. The feeding strategy of the production method is: when the glycerol concentration in the fermentation medium (i.e., the fermentation liquid in the fermenter) is less than 10g / L, glycerol is added to the fermentation medium so that the final glycerol concentration in the fermentation medium is not less than 20g / L; when the cell density index OD600nm reaches 20, the temperature is lowered to an induction temperature of 32°C, and isopropyl-β-D-thiogalactopyranoside and a-lactose mother liquor are added to the fermentation medium so that the final lactose concentration in the fermentation medium reaches 10g / L; the lactose concentration in the fermentation medium is monitored, and when the lactose concentration is less than 5g / L, a-lactose is added to the fermentation medium so that the fermentation medium is not less than 20g / L. The lactose concentration in the culture medium is not less than 10 g / L; the a-lactose mother solution is prepared separately, heated to 60° C., sodium hydroxide is added to adjust the pH to 10-11, and then sterilized at 115° C. for 30 minutes, cooled to 60° C. for insulation, and used in the feeding procedure; the pH and dissolved oxygen content of the fermentation medium are monitored, the pH of the fermentation medium is controlled to be 6.6-6.8 by feeding a pH regulator, the ventilation volume is controlled to be 1.0 vvm-2.0 vvm, and the speed of the stirring paddle is controlled to be 200 rpm-700 rpm.
[0008] Preferably, the fermentation medium of the production method comprises: 20 g / L glycerol, 5 g / L KH2PO4, 5 g / L K2HPO4, 4.0 g / L (NH4)2SO4, 1.7 g / L citric acid monohydrate, 1.4 g / L MgSO4·7H2O, 4.5 mg / L thiamine and 1% by volume of trace elements, and the pH is adjusted to 6.8 with sodium hydroxide; wherein the trace element liquid comprises: 10 g / L FeSO4·7H2O, 2.2 g / L ZnSO4·7H2O, 1.0 g / L CuSO4·5H2O, 0.38 g / L MnSO4·H2O, 0.02 g / L Na2B4O7·10H2O, 0.14 g / L (NH4)6Mo7O 24 0.1g / L and CaCl2 2.0g / L, dissolved in 5 mol / L hydrochloric acid.
[0009] Preferably, the carbon source feed solution used in the production method is: 800 g / L glycerol; the α-lactose mother liquor solvent used in the production method is water, and the α-lactose concentration in the α-lactose mother liquor is 650 g / L.
[0010] Preferably, the pH regulator for the production method is 50% by volume of aqueous ammonia.
[0011] Preferably, when the temperature of the fermentation medium is lowered to the induction temperature of 32°C, isopropyl-β-D-thiogalactopyranoside is added to the fermentation medium so that the final concentration of the isopropyl-β-D-thiogalactopyranoside solution in the fermentation medium is 0.2 mmol / L.
[0012] Preferably, the inoculation amount of the seed culture solution in the fermenter in the production method is 3%. Beneficial Effects
[0013] The present invention finds in the research on the fed-batch fermentation process of 3-fucosyllactose that the improvement of the feeding strategy is beneficial to increasing the yield of 3-fucosyllactose, and the pretreatment of the α-lactose feeding solution increases the yield of 3-fucosyllactose per unit time, which is beneficial to improving the production efficiency of 3-fucosyllactose and better meeting market demand. Implementation
[0014] The scheme of the present invention is shown and described in more detail below by specific examples. Unless otherwise specified, the technical means used in the present invention are methods known to those skilled in the art. In addition, the embodiments should be understood as illustrative rather than limiting the scope of the present invention, and the essence and scope of the present invention are limited only by the claims. For those skilled in the art, various changes or modifications to the material composition and dosage in these embodiments, without departing from the essence and scope of the present invention, also belong to the protection scope of the present invention.
[0015] In the following examples, the concentration of lactose and 3-fucosyllactose in the fermentation medium was detected by HPLC. The chromatographic column used for HPLC analysis was Carbohydrate ES 5u 250mmx4.6mm, the detector was an evaporative light detector, the mobile phase was 70% acetonitrile (acetonitrile: water), the flow rate was 0.8mL / min, the column temperature was set at 30°C, and the injection volume was 5µL. The method reported in the literature can also be used for detection: Christensen AS, Skov SH, Lendal SE, et al . Quantifyingthe human milk oligosaccharides 2'-fucosyllactose and 3-fucosyllactose indifferent food applications by high-performance liquid chromatography withrefractive index detection[J]. Journal of Food Science, 2020, 85(2):332-338. In the following examples, the glycerol concentration, pH, dissolved oxygen content, etc. in the fermentation medium were monitored by a sensor analyzer equipped with the fermenter.
[0016] Example 1 Construction of strain HCYJ-08, i.e., Escherichia coli CGMCC No. 27189 Since the Escherichia coli strain TKYW3 (pTrc99a-P trc - footA - andC ) The construction method of the strain HCYJ-08 (Escherichia coli CGMCC NO.27189) described in the present invention has not been published. This section cites the content of Chinese patent application CN2022116286408 to illustrate the construction of strain HCYJ-08, i.e., Escherichia coli CGMCC NO.27189. The writing order of the primer sequences in this embodiment is from 5' to 3'. The nucleotide sequence numbers and amino acid sequence numbers involved in this embodiment are summarized as follows: P lac The nucleotide sequence of the promoter is shown as sequenceIDNumber: 1; lacI The nucleotide sequence is shown as sequenceIDNumber:2; lacZ The nucleotide sequence of P is shown in sequenceIDNumber:3; trc The nucleotide sequence of the promoter is shown as sequenceIDNumber:4; wcaG The nucleotide sequence is shown as sequenceIDNumber:5; gmd The nucleotide sequence is shown as sequenceIDNumber:6; lacY The nucleotide sequence is shown as sequenceIDNumber:7; adhE The nucleotide sequence is shown as sequenceIDNumber:8; andA The nucleotide sequence is shown as sequenceIDNumber:9; andB The nucleotide sequence is shown as sequenceIDNumber:10; wcaj The nucleotide sequence is shown as sequenceIDNumber:11; paint The nucleotide sequence of the gene and its promoter is shown in sequenceIDNumber:12; he nudged The gene nucleotide sequence is shown as sequenceIDNumber:13; setA The nucleotide sequence of the gene is shown in sequenceIDNumber:14; the methionine aminopeptidase mutant in which the isoleucine at position 44 is mutated to serine (Map Ile44Ser ) The amino acid sequence is shown in sequenceIDNumber:15; P ara The nucleotide sequence of the promoter is shown as sequenceIDNumber:16; andCThe nucleotide sequence is shown as sequenceIDNumber:17; footC The nucleotide sequence of the plasmid is shown in sequence ID Number: 18; trc - footC - andC The nucleotide sequence of the artificially synthesized footA The nucleotide sequence of the gene fragment is as follows: sequenceIDNumber: 20; footA The nucleotide sequence of the gene fragment is as follows: sequenceIDNumber: 21; encoding a methionine aminopeptidase mutant (Map Ile44Ser ) is shown as sequenceIDNumber:22; the nucleotide sequence of the promoter of the chloramphenicol resistance gene is shown as sequenceIDNumber:23; and the amino acid sequence of the wild-type methionine aminopeptidase is shown as sequenceIDNumber:24.
[0017] 1.1 Construction of strain TKYW2-2 In the patent document CN112501106A, Escherichia coli W2 ( E.coli K12 MG1655△ lacIZ ::P trc - wcaG-gmd-lacy, △ adhE ::P trc - andB-andA ) based on the knockout of the UDP-glucose lipid carrier transferase encoding gene in the genome wcaj and GDP-mannose hydrolase encoding genes he nudged , further overexpressing sugar efflux transporter genes in situ in the genome setA , strain TKYW2-2 was constructed.
[0018] The Escherichia coli W2 in CN112501106A is based on Escherichia coli K12 MG1655 ( Escherichia coli K12 MG1655) was constructed as the starting strain, and the P in the lactose lac operon sequence of the starting strain was knocked out. lac Promoter sequences and regulatory genes lacI and β- β-galactosidase encoding gene lacZ , in the original lacZ P trc Promoter overexpresses GDP-fucose synthase encoding gene wcaG、 GDP-mannose-4,6-dehydratase encoding gene gmd and β- Galactoside permease encoding gene lacY The W1 strain was obtained, and the gene encoding alcohol dehydrogenase was half P trc Promoter overexpression of phosphomannose isomerase encoding gene andA and phosphomannose mutase encoding genes andB The W2 strain was obtained. 1.1.1 Construction of strain W2△ wcaj Using strain W2 as the starting strain, CRISPR / Cas9 technology was used to knock out wcaj (The nucleotide sequence is shown in sequenceIDNumber: 11). The CRISPR / Cas9 technology used in the experiment refers to previous research reports (Zhao D, et al . CRISPR / Cas9-assisted gRNA-free one-step genome editing with nosequence limitations and improved targeting efficiency. Sci Rep 7, 16624). First, the first homologous recombination fragment was constructed, including the upstream and downstream homologous arms and the chloramphenicol resistance gene. paint and the universal N20+NGG sequence (TAGTCCATCGAACCGAAGTAAGG), the first step homologous recombination fragment was introduced into the W2 strain containing the pCAGO plasmid by electroporation for the first step recombination. The pCAGO plasmid contains the recombinase gene, as well as cas9 and gRNA genes (Zhao D, et al . CRISPR / Cas9-assisted gRNA-free one-step genome editing with nosequence limitations and improved targeting efficiency. Sci Rep 7, 16624). Select the correct clone and perform the second homologous recombination. Select the correct clone after the second homologous recombination and pass down the pCAGO plasmid to obtain the knockout wcaj W2△ wcaj strains.
[0019] The following describes the specific method in detail: (1) The first step is to construct the homologous recombination fragment. E . coliK12 MG1655 genome (GeneBank accession NO. NC_000913) was used as a template, and primers up-1 and up-2, as well as primers down-1 and down-2 in Table 1 were used to amplify the upstream and downstream homology arms of homologous recombination. paint (The nucleotide sequence is shown in sequenceIDNumber:12, sequenceIDNumber:12 is paint The genome of the strain containing the nucleotide sequence of the gene and its promoter was used as a template, and PCR amplification was performed using primers cat-1 and cat20-2 to obtain a paint- The fragment of N20 sequence. The upper and downstream homology arms, with paint- The fragments of N20 sequence were used as templates and overlapped PCR amplification was performed using primers up-1 and down-2 to obtain the first step homologous recombination fragments.
[0020] (2) First step homologous recombination. The pCAGO plasmid was transformed into strain W2 using conventional plasmid transformation methods to obtain strain W2 (pCAGO). W2 (pCAGO) competent cells were prepared using LB medium containing 1% glucose and 0.1 mM IPTG (isopropyl-β-D-thiogalactopyranoside). The first homologous recombination fragment was introduced using electroporation. The transformed bacterial liquid was spread on LB plates containing 100 mg / L ampicillin and 25 mg / L chloramphenicol, as well as 1% glucose, and cultured at 30°C. Transformants were picked for colony PCR identification to obtain the correct first step homologous recombination strain.
[0021] (3) Second step of homologous recombination. The first step homologous recombination strain was inoculated into LB liquid medium containing 100 mg / L ampicillin, 0.1 mM IPTG and 2 g / L arabinose, and cultured at 30°C for more than 6 hours. Single colonies were isolated by streaking on a plate, and clones that could grow on LB plates containing 100 mg / L ampicillin but could not grow on LB plates containing 25 mg / L chloramphenicol were screened. Sequencing confirmed the correct clone that underwent the second homologous recombination, and further cultured it at 37°C to lose the pCAGO plasmid, thereby obtaining strain W2△ wcaj .
[0022] Table 1 Knockout wcaj Primers used for genes
[0023] 1.1.2 Construction of strain W2△
[0024] In Escherichia coli strain W2△ wcaj Based on the above CRISPR / Cas9 technology, the same method is used to knock out he nudged gene (nucleotide sequence is shown in sequenceIDNumber:13), and strain W2△ wcaj △ he nudged , named ZKYW1. The specific method is described in detail below: (1) The first step is to construct the homologous recombination fragment. E . coli K12 MG1655 genome was used as a template, and the upstream and downstream homology arms of homologous recombination were amplified by PCR using the primer pairs Nup-1 and Nup-2 and the primer pairs Ndown-1 and Ndown-2 in Table 2, respectively. wcaj When obtained with paint- The fragment of N20 sequence was used as template, and PCR amplification was performed using primers Ncat-1 and Ncat20-2 in Table 2 to obtain a new paint- The fragment of N20 sequence. The homology arms above and downstream, the new paint- The three fragments of N20 sequence were used as templates and overlapped PCR amplification was performed using primers Nup-1 and Ndown-2 to obtain the first step homologous recombination fragments.
[0025] (2) First step: homologous recombination. The pCAGO plasmid was transformed into strain W2△ using conventional plasmid transformation methods. wcaj The strain W2△ was obtained wcaj (pCAGO). W2△ was prepared using LB medium containing 1% glucose and 0.1 mM IPTG. wcaj The first homologous recombination fragment was introduced into the competent state of (pCAGO) by electroporation, and the transformed bacterial solution was spread on LB plates containing 100 mg / L ampicillin, 25 mg / L chloramphenicol, and 1% glucose and cultured at 30°C. The transformants were picked for colony PCR identification to obtain the correct first homologous recombination strain.
[0026] (3) The second step is homologous recombination. wcaj The steps of the second homologous recombination were the same as those of the gene. The correct clone that underwent the second homologous recombination was obtained by sequencing and further cultured at 37°C to lose the pCAGO plasmid, thus obtaining strain W2△ wcaj △ he nudged , named TKYW1.
[0027] Table 2 Knockout he nudged Primers used for genes
[0028] 1.1.3 Construction of strain TKYW2-2
[0029] Based on strain TKYW1, the same method as the above-mentioned CRISPR / Cas9 technology was used to clone the sugar efflux transporter. setA The constitutive promoter P is inserted in front of the gene (nucleotide sequence is shown in sequenceIDNumber:14). J23110 (http: / / parts.igem.org / Part:BBa_J23100), promoter P J23110 The sequence is: TTTACGGCTAGCTCAGTCCTAGGTACAATGCTAGC; at the same time, when CRISPR / Cas9 is used for the second recombination, the promoter of the chloramphenicol resistance gene (nucleotide sequence is shown in sequenceIDNumber:23) is retained to achieve dual promoter pairing. setA In situ overexpression was performed and the resulting strain was named TKYW2-2.
[0030] (1) The first step is to construct the homologous recombination fragment. E . coli K12 MG1655 genome was used as a template, and the primer pairs Sup-1 and Sup-2 and primer pairs Sdown-1 and Sdown-2 in Table 3 were used as primers to PCR amplify the upstream and downstream homology arms of homologous recombination. wcaj When obtained with paint- The fragment of N20 sequence was used as template, and PCR amplification was performed using primers Scm-1 and Scm-2 in Table 3 to obtain paint Using N20-1 as the upstream primer and 110-2 as the downstream primer, PCR amplification was performed without using a template to obtain a fragment with P J23110 Using Sup-1 and Sdown-2 as primers, the upstream homology arm obtained by PCR amplification, paint Fragments of gene sequences, with P J23110 The promoter gene fragment and the downstream homologous arm, a total of 4 fragments, were used as templates for overlapping PCR amplification to obtain the fragment for the first step of homologous recombination.
[0031] Table 3 Constructs overexpressed in the genome setA Primers used for strains expressing genes
[0032] (2) First step of homologous recombination. The pCAGO plasmid was transformed into the strain TKYW1 using conventional plasmid transformation methods to obtain strain TKYW1 (pCAGO). TKYW1 (pCAGO) competent cells were prepared using LB medium containing 1% glucose and 0.1 mM IPTG, and the above-mentioned fragments for the first homologous recombination were introduced using the electroporation method. The transformed bacterial liquid was spread on LB plates containing 100 mg / L ampicillin and 25 mg / L chloramphenicol, as well as 1% glucose, and cultured at 30°C. Transformants were picked for colony PCR identification to obtain the correct first step homologous recombination strain.
[0033] (3) The second step is homologous recombination. wcaj The steps of the second homologous recombination were the same as those of the first gene. The correct clone that underwent the second homologous recombination was obtained by sequencing and further cultured at 37°C to lose the pCAGO plasmid, thereby obtaining a clone with P J23110 The strain expressing the promoter was named TKYW2-2.
[0034] 1.2 Construction of strain TKYW3 The amino acid sequence of the wild-type methionine aminopeptidase of Escherichia coli K12 MG1655 is shown in sequence ID Number: 24. Based on strain TKYW2-2, the methionine aminopeptidase gene on the genome was mutated using the same method as the above-mentioned CRISPR / Cas9 technology. map Point mutation was performed. The 44th isoleucine of its translated protein was mutated to serine (Map Ile44Ser ), the amino acid sequence corresponding to the methionine aminopeptidase mutation is shown in sequenceIDNumber:15, and the constructed strain is named TKYW3.
[0035] 1.2.1 The first step is the construction of homologous recombination fragments A laboratory-preserved strain with map MG1655 mutant with gene point mutation map T131G ( map T131G The nucleotide sequence is shown in sequenceIDNumber:22) as a template, and the primer pairs Mup-1 and Mup-2 and the primer pairs Mdown-1 and Mdown-2 in Table 4 are used as primers to amplify the upstream and downstream homologous arms of homologous recombination by PCR. wcaj The PCR-derived paint- The fragment of N20 sequence was used as template and PCR amplification was performed using primers Mcat-1 and Mcat20-2 to obtain a new paint- The fragment of N20 sequence. The homology arms above and downstream, the new paint- The three fragments were used as templates, and overlapping PCR was performed using primers Mup-1 and Mdown-2 to obtain the first homologous recombination fragment, which contained map Point mutation of the gene, i.e. wild type map The 131st base of the gene changes from T to G.
[0036] 1.2.2 First step: homologous recombination The pCAGO plasmid was transformed into strain TKYW2-2 using conventional plasmid transformation methods to obtain strain TKYW2-2 (pCAGO). TKYW2-2 (pCAGO) competent cells were prepared using LB medium containing 1% glucose and 0.1 mM IPTG, and the first homologous recombination fragment was introduced using electroporation. The transformed bacterial solution was spread on LB plates containing 100 mg / L ampicillin and 25 mg / L chloramphenicol, as well as 1% glucose, and cultured at 30°C. Transformants were picked for colony PCR identification to obtain the correct first homologous recombination strain.
[0037] 1.2.2 Second step homologous recombination With the above knockout wcaj The steps of the second homologous recombination were the same as those of the second homologous recombination. The correct clone that underwent the second homologous recombination was obtained by sequencing and further cultured at 37°C to lose the pCAGO plasmid, thereby obtaining strain TKYW2-2. map T131G , named TKYW3.
[0038] Table 4 Construction map Primers used for gene point mutation strains
[0039] 1.3 Construction of plasmid pTrc99a-P trc - footC - andC The plasmid pTrc99a- futC-andC As template (plasmid pTrc99a- futC-andC Constructing the P trc The nucleotide sequence of the promoter is shown in sequenceIDNumber:4; arabinose-inducible promoter P ara The nucleotide sequence of the promoter is shown in sequenceIDNumber:16; Mannosyl-1-phosphate guanylyltransferase encoding gene andCThe nucleotide sequence is shown in sequenceIDNumber:17; 2'-fucosyllactose synthase encoding gene footC The nucleotide sequence is shown in sequenceIDNumber: 18), PCR amplification was performed using Darac-F and Darac-R in Table 5 as primers, and the PCR product was purified and recovered, and then self-ligated using seamless cloning enzyme (pEASY-UniSeamlessCloning and Assembly Kit, Beijing Quanshijin Biotechnology Co., Ltd.) and transformed into Escherichia coli. E . coli JM109 competent cells were cultured on LB plates containing 100 mg / L ampicillin, and transformants were selected for sequencing verification to obtain the correct recombinant plasmid, which was named plasmid pTrc99a-P trc - footC - andC , whose nucleotide sequence is shown in sequenceIDNumber:19.
[0040] Table 5 Construction of plasmid pTrc99a-P trc - footC - andC Primers used
[0041] 1.4 Plasmid pTrc99a-P trc - footA - andC Build Using Helicobacter pylori ( Helicobacter pylori ) α-(1,3)-fucosyltransferase gene from NCTC 11637 footA Replace plasmid pTrc99a-P trc - footC - andC In footC , construct plasmid pTrc99a-P trc - footA - andC FutA can catalyze the production of 3-fucosyllactose using GDP-fucose and lactose as substrates.
[0042] Plasmid pTrc99a-P trc - footA - andC As a template, PCR amplification was performed using FUTA-ZT-F and FUTA-ZT-R in Table 6 as primers to obtain the removal footC A linear vector fragment containing footAThe vector containing the gene fragment (nucleotide sequence as shown in sequenceIDNumber:20) is used as a template (the gene fragment contains the nucleotide sequence as shown in sequenceIDNumber:21 footA Gene), PCR amplification was performed using FUTA-F and FUTA-R as primers to obtain footA After the two PCR products were purified and recovered, they were connected using seamless cloning enzymes and transformed into E . coli JM109 competent cells were cultured on LB plates containing 100 mg / L ampicillin, and transformants were selected for sequencing verification to obtain the correct recombinant plasmid, which was named pTrc99a-P trc - footA - andC .
[0043] Table 6 Construction of plasmid pTrc99a-P trc - footA - andC Primers used
[0044] 1.5 Construction of 3-fucosyllactose-producing strain HCYJ-08, i.e., Escherichia coli CGMCC No. 27189 The plasmid pTrc99a-P trc - footA - andC The 3-fucosyllactose-producing strain TKYW3 (pTrc99a-P trc - footA - andC ), named HCYJ-08, namely Escherichia coli CGMCCNO.27189.
[0045] Example 2 Comparison of fed-batch fermentation methods for producing 3-fucosyllactose Production strain: HCYJ-08, i.e. Escherichia coli CGMCC NO.27189.
[0046] Seed / fermentation medium: glycerol 20g / L, KH2PO4 5g / L, K2HPO4 5g / L, (NH4)2SO4 4.0g / L, citric acid monohydrate 1.7g / L, MgSO4·7H2O 1.4g / L, thiamine 4.5mg / L and trace elements 1% (v / v), adjusted to pH 6.8 with sodium hydroxide. Trace element solution: FeSO4·7H2O 10g / L, ZnSO4·7H2O 2.2g / L, CuSO4·5H2O 1.0g / L, MnSO4·H2O 0.38g / L, Na2B4O7·10H2O 0.02g / L, (NH4)6Mo7O 24 0.1g / L and CaCl2 2.0g / L, dissolved in 5 mol / L hydrochloric acid.
[0047] Feed solution for batch fed fermentation: (1) Feed carbon source: 800 g / L glycerol; (2) Feed lactose: 650 g / L lactose, first heated to 60°C and adjusted to pH 10-11 with sodium hydroxide, then sterilized at 115°C for 30 min, and then cooled to 60°C for insulation; pH adjuster: 50% ammonia water (v / v).
[0048] Cultivation steps: First-stage seed shake flask: Take the HCYJ-08 glycerol tube strain and inoculate it into the seed culture medium. Culture it at 37°C and a shaker speed of 180 rpm for 12 hours to obtain the first-stage seed culture solution.
[0049] Secondary seed shake flask: inoculate the primary seed culture solution into the seed culture medium at a rate of 2% (V / V), and culture at 37°C and 180 rpm for 8 hours to obtain the secondary seed culture solution, i.e., the seed solution.
[0050] Fermentation tank culture: A 100L fermentation tank was used, 40L of fermentation medium was added, and the secondary seed culture solution, i.e., the seed solution, was inoculated into the fermentation medium at a 3% (V / V) inoculation rate. The reactor used a glycerol-restricted medium. Studies have shown that glycerol is more suitable as a carbon source for the production of 3-fucosyllactose (3-FL) than glucose, and provides a skeleton for the synthesis of GDP-L-fucose, the precursor of 3-FL. As the only carbon source, it plays an important role in cell growth and intermediate synthesis.
[0051] In this reaction, as the substrate is consumed, the concentration of glycerol gradually decreases. The glycerol concentration in the bioreactor system is monitored by a biosensor analyzer. When the glycerol concentration is lower than 10 g / L, glycerol is added to ensure that the final concentration is not lower than 20 g / L.
[0052] When the cell density index OD600nm in the bioreactor reaches 20, the temperature is lowered to the induction temperature of 32°C, and isopropyl-β-D-thiogalactopyranoside (IPTG) and a-lactose mother liquor are added simultaneously to make the final lactose concentration in the fermentation medium reach 10 g / L, and the final IPTG concentration is 0.2 mmol / L. At the same time, the lactose concentration in the fermentation broth is monitored by HPLC. When the lactose concentration is lower than 5 g / L, lactose is added to ensure that its concentration is not lower than 10 g / L.
[0053] In the batch-fed fermentation adopted in this process, the pH index and dissolved oxygen content in the fermentation system are detected in real time by setting a computer program, and the pH regulator ammonia water is added to the fermentation system at a certain speed through the associated program to control the pH index in the fermentation system to be maintained at 6.7±0.1. The dissolved oxygen content is detected through the associated program to control the ventilation range to 1.0vvm~2.0 vvm and the stirring blade speed to 200rpm~700rpm. The results of the batch-fed fermentation of the 3-FL engineered recombinant strain were obtained by fermenting the recombinant strain HCYJ-08 in a 100L fermenter, monitoring the concentrations of lactose, glycerol and 3-FL during the process, and tracking the cell concentration in the bioreactor.
[0054] After 10 hours of fermentation, the cell density at 600 nm (OD600nm) was 20. IPTG with a final concentration of 0.2 mmol / L was then added to induce the expression of related enzymes. At the same time, a-lactose with a final concentration of 10 g / L was added as a substrate. When the production of 3-FL in the fermentation system no longer increased, the fermentation was terminated. Finally, the concentration of 3-FL in the fermenter reached 52.71 g / L, and the maximum cell density reached 72.70.
[0055] A control fermentation process was also set up, in which the α-lactose mother liquor was not kept at 60°C and pretreated with NaOH after sterilization, and other conditions were the same.
[0056] The fermentation process test results of the two processes are shown in Tables 7 and 8, respectively. It can be seen from Table 7 that the 3-FL production per unit time of the process of batch feeding fermentation after pretreatment of a-lactose mother liquor is higher than that of the control fermentation process. It can be seen from Table 8 that the cell density index OD600nm per unit time of the process of batch feeding fermentation after pretreatment of a-lactose mother liquor is slightly different from that of the control fermentation process.
[0057] Table 7 Dynamic detection results of 3-FL production in two fermentation processes
[0058] Table 8 Dynamic detection results of cell density OD600nm of two fermentation processes
[0059] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A fed-batch fermentation method for producing 3-fucosyllactose, characterized in that: The production method uses Escherichia coli with a preservation number of CGMCC NO.27189 to ferment and produce 3-fucosyllactose; the production method uses glycerol as a carbon source, and the feeding strategy of the production method is: when the glycerol concentration in the fermentation medium is less than 10g / L, glycerol is added to the fermentation medium so that the final glycerol concentration in the fermentation medium is not less than 20g / L; when the cell density index OD600nm reaches 20, the temperature is reduced to an induction temperature of 32°C, and isopropyl-β-D-thiogalactopyranoside and a-lactose mother liquor are added to the fermentation medium so that the final lactose concentration in the fermentation medium reaches 10g / L; when the fermentation medium is heated to 40 ℃, the temperature is reduced to 20 ℃, and the temperature is reduced to 32 ℃, and the temperature is reduced to 20 ℃. When the lactose concentration in the culture medium is less than 5 g / L, α-lactose is added to the fermentation culture medium so that the lactose concentration in the fermentation culture medium is not less than 10 g / L; the α-lactose mother liquor is prepared separately, heated to 60° C., sodium hydroxide is added to adjust the pH to 10-11, and then sterilized at 115° C. for 30 minutes, cooled to 60° C. for insulation, and used for the feeding procedure; the pH and dissolved oxygen content of the fermentation culture medium are monitored, and a pH regulator is added to control the pH of the fermentation culture medium to be 6.6-6.8; during the fermentation process, the ventilation volume is controlled to be 1.0 vvm-2.0 vvm and the speed of the stirring paddle is controlled to be 200 rpm-700 rpm.
2. The production method according to claim 1, characterized in that The fermentation medium used in the production method comprises: 20 g / L glycerol, 5 g / L KH2PO4, 5 g / L K2HPO4, 4.0 g / L (NH4)2SO4, 1.7 g / L citric acid monohydrate, 1.4 g / L MgSO4·7H2O, 4.5 mg / L thiamine and 1% by volume of trace elements, and the pH is adjusted to 6.8 with sodium hydroxide; wherein the trace element liquid comprises: 10 g / L FeSO4·7H2O, 2.2 g / L ZnSO4·7H2O, 1.0 g / L CuSO4·5H2O, 0.38 g / L MnSO4·H2O, 0.02 g / L Na2B4O7·10H2O, 0.1 g / L (NH4)6Mo7O 24 0.1g / L and CaCl2 2.0g / L, dissolved in 5 mol / L hydrochloric acid.
3. The production method according to claim 1, characterized in that: The carbon source feed solution used in the production method is: 800 g / L glycerol; the solvent of the a-lactose mother liquor used in the production method is water, and the a-lactose concentration in the a-lactose mother liquor is 650 g / L.
4. The production method according to claim 1, characterized in that The pH regulator for the production method is 50% ammonia water by volume.
5. The production method according to claim 1, characterized in that: In the production method, when the fermentation medium is cooled to an induction temperature of 32° C., isopropyl-β-D-thiogalactopyranoside is added to make the final concentration of isopropyl-β-D-thiogalactopyranoside in the fermentation medium 0.2 mmol / L.
6. The production method according to claim 1, characterized in that: The inoculation amount of the seed culture solution in the fermentation tank of the production method is 3%.
